Talphera Management
Management criteria checks 3/4
Talphera's CEO is Vince Angotti, appointed in Mar 2017, has a tenure of 7.08 years. total yearly compensation is $1.30M, comprised of 49.1% salary and 50.9% bonuses, including company stock and options. directly owns 0.55% of the company’s shares, worth $97.27K. The average tenure of the management team and the board of directors is 11.8 years and 7.1 years respectively.
Key information
Vince Angotti
Chief executive officer
US$1.3m
Total compensation
| CEO salary percentage | 49.1% |
| CEO tenure | 7.1yrs |
| CEO ownership | 0.5% |
| Management average tenure | 11.8yrs |
| Board average tenure | 7.1yrs |
Recent management updates
Recent updates
AcelRx: The Catalogue Of Catalysts - Including A Big One That Will Do Investors Well
Aug 18AcelRx Pharmaceuticals: Finally, Plan B
Jun 06AcelRx Pharmaceuticals: Making Sense Of The Q4 Numbers
Mar 16AcelRx Pharmaceuticals: The Fog Is Getting Thicker
Jan 14AcelRx: Battered And Bruised But Ready For Recovery In 2022
Jan 05AcelRx Pharmaceuticals: Is Wayne Gretzky Right Or The Puck?
Oct 02AcelRx Pharmaceuticals: How The Licensing Agreements Could Become A Shot In The Arm
Jul 27FDA agrees with AcelRx to update promotional materials for Dsuvia
Jun 17Shareholders May Find It Hard To Justify Increasing AcelRx Pharmaceuticals, Inc.'s (NASDAQ:ACRX) CEO Compensation For Now
Jun 11
AcelRx Pharmaceuticals: A Bullish View In 3 Song Titles
May 31When Will AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Turn A Profit?
Feb 03
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$10m |
| Sep 30 2023 | n/a | n/a | -US$11m |
| Jun 30 2023 | n/a | n/a | -US$14m |
| Mar 31 2023 | n/a | n/a | US$42m |
| Dec 31 2022 | US$1m | US$637k | US$54m |
| Sep 30 2022 | n/a | n/a | US$69m |
| Jun 30 2022 | n/a | n/a | US$65m |
| Mar 31 2022 | n/a | n/a | -US$31m |
| Dec 31 2021 | US$2m | US$637k | -US$17m |
| Sep 30 2021 | n/a | n/a | -US$36m |
| Jun 30 2021 | n/a | n/a | -US$37m |
| Mar 31 2021 | n/a | n/a | -US$33m |
| Dec 31 2020 | US$2m | US$637k | -US$40m |
| Sep 30 2020 | n/a | n/a | -US$46m |
| Jun 30 2020 | n/a | n/a | -US$50m |
| Mar 31 2020 | n/a | n/a | -US$55m |
| Dec 31 2019 | US$2m | US$618k | -US$53m |
| Sep 30 2019 | n/a | n/a | -US$51m |
| Jun 30 2019 | n/a | n/a | -US$51m |
| Mar 31 2019 | n/a | n/a | -US$49m |
| Dec 31 2018 | US$2m | US$600k | -US$47m |
| Sep 30 2018 | n/a | n/a | -US$44m |
| Jun 30 2018 | n/a | n/a | -US$45m |
| Mar 31 2018 | n/a | n/a | -US$48m |
| Dec 31 2017 | US$2m | US$493k | -US$52m |
Compensation vs Market: Vince's total compensation ($USD1.30M) is above average for companies of similar size in the US market ($USD673.68K).
Compensation vs Earnings: Vince's compensation has been consistent with company performance over the past year.
CEO
Vince Angotti (55 yo)
7.1yrs
Tenure
US$1,297,016
Compensation
Mr. Vincent J. Angotti, also known as Vince, has been the Chief Executive Officer of Talphera, Inc. (formerly known as AcelRx Pharmaceuticals, Inc.) since March 6, 2017. Mr. Angotti served as the Chief Exe...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 7.1yrs | US$1.30m | 0.55% $ 97.3k | |
| Co-Founder & Chief Medical Officer | 18.8yrs | US$822.40k | 0.21% $ 36.8k | |
| Chief Financial Officer | 6.7yrs | US$755.14k | 0.082% $ 14.6k | |
| Chief Engineering Officer | 16.6yrs | US$686.35k | 0.070% $ 12.5k |
11.8yrs
Average Tenure
57.5yo
Average Age
Experienced Management: TLPH's management team is seasoned and experienced (11.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 7.1yrs | US$1.30m | 0.55% $ 97.3k | |
| Independent Director | 17.7yrs | US$76.50k | 0.011% $ 1.9k | |
| Independent Director | 14.2yrs | US$56.50k | 0.011% $ 1.9k | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Independent Chairman | 11.2yrs | US$111.50k | 0.066% $ 11.7k | |
| Independent Director | 3.1yrs | US$66.50k | 0.010% $ 1.9k | |
| Independent Director | 2.4yrs | US$66.50k | 0.0060% $ 1.1k | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Director | less than a year | no data | no data |
7.1yrs
Average Tenure
59.5yo
Average Age
Experienced Board: TLPH's board of directors are considered experienced (7.1 years average tenure).